Press Release
SHERLOCK Biosciences in the News.
News Overview
Read about Sherlock’s work to revolutionize molecular diagnostics and bring highly accurate, rapid, and affordable testing to the world.
Media Inquiries
press@sherlock.bio
November 18, 2021
Sherlock Biosciences Named to Fast Company’s First-Ever List of the Next Big Things in TechNovember 18, 2021
- Fast Company
Thanks to CRISPR, this at-home COVID-19 test is both fast and accurateJuly 27, 2021
- Biospace
Sherlock Biosciences’ CEO: “It’s Better to Be Disruptive Than to Follow the Crowd9:00am –11:00am EDT, Wednesday, August 11, 2021
Virtual Event: BIOTECH IN BOSTON: Leading the way in life sciences with Bryan DechairoJuly 12, 2021
- Fierce Biotech
Sherlock Biosciences solves C-suite mystery, tapping Myriad Genetics’ Dechairo as CEOJuly 12, 2021
Sherlock Biosciences Announces Appointment of Bryan Dechairo as President and Chief Executive OfficerJune 22, 2021
Sherlock Biosciences’ 221b Foundation Enables Global Access to COVID-19 Diagnostics with Up To 10 Million Tests Per MonthJune 02, 2021
Sherlock Biosciences Announces Initial Results of Automation Study with NorDx Laboratories on CRISPR-based Test for SARS-CoV-212:00 PM - 12:45 PM (EDT), Monday, June 14, 2021
BIO Digital International Convention – Diagnosing the Future: The Impact of the COVID-19 Pandemic on Diagnostics with Rahul DhandaMay 04, 2021
- Fast Company
World Changing Ideas Awards 2021: Pandemic Response Finalists and Honorable MentionsMay 04, 2021
- Genetic Engineering & Biotechnology News
COVID, CRISPR, and a Commitment to Global Health: An Interview with Sherlock Bio’s Rahul DhandaMay 03, 2021
- Forbes
The Pandemic Changed The Future Of Crispr – Here’s What Comes Next Says This Crispr CEOApril 21, 2021
The 221b Foundation Grants Licenses to Multiple Organizations to Develop and Distribute CRISPR COVID-19 Diagnostic Kits GloballyMay 26th, 4pm ET
SynBioBeta BioPharma Virtual Conference featuring Rahul DhandaMarch 09, 2021
Sherlock Biosciences Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021March 01, 2021
How Sherlock’s COVID-19 Test Detects Variants
February 15th-17th, 2021: IFCC
Virtual Event: IFCC Global Conference on COVID-19 – Presentation by Will Blake, CTO: CRISPR and Synthetic Biology-based Solutions Applied to COVID-19 DiagnosisFebruary 18th, 2021 6pm ET: HBCU First
Virtual Event: HBCU First Career Talk – Sherlock Biosciences talks biotech careers and better health with Tiffany Summerville, Joel Mowatt, Fred NyachieoFebruary 17th, 2021 10:30am ET: BTIG
Virtual Event: Fireside chat with CEO, Rahul Dhanda – BTIG Virtual MedTech, Digital Health, Life Sciences & Diagnostic Tools ConferenceFebruary 08, 2021
The Vision: Co-founders Rahul Dhanda and Jim Collins Q&A
January 22, 2021
What is Synthetic Biology?
January 06, 2021
- The Chronicle of Philanthropy
Gates Foundation Commits Additional $250 Million for COVID-19 Tests, Vaccines, and TreatmentsJanuary 06, 2021
The 221b Foundation Establishes Coalition to Control the Spread of COVID-19 in NepalDecember 29, 2020
Limitations of Testing
December 16, 2020
Sherlock Biosciences Receives $5 Million Grant to Advance INSPECTR™ Platform for COVID-19 Self-testDecember 10, 2020
Sherlock Employee Testimony: Elizabeth Phillips
December 07, 2020
Sherlock Biosciences Announces Discovery of Novel CRISPR-Cas Enzymes, Enabling Simple Multiplex Diagnostic SolutionsDecember 04, 2020
Sherlock Biosciences Strengthens Intellectual Property Portfolio in CRISPR-based Diagnostics Through Exclusive License Agreement with Tolo BiotechNovember 19, 2020
Sherlock Employee Testimony: Carl Brown
November 05, 2020
Sherlock Employee Testimony: Christine Coticchia
November 4, 2020 1pm-2pm: MassMEDIC
Virtual Event: 2020 MassMEDIC Medtech Showcase Panel: “The Insiders Perspective: Getting a Medtech Investment”November 4, 2020 4:00pm –5:30pm ET - Boston Business Journal
Virtual Event: 2020 Power 50: Extraordinary Year, Extraordinary PeopleNovember 02, 2020
- Forbes
There Is No Silver Bullet Coronavirus Test, But Here’s How Diagnostics Can HelpOctober 08, 2020
Sherlock Employee Testimony: Paul Carlson:
October 06, 2020
- Boston Business Journal
COVID gave this startup its first sales. Here’s why it’s giving that money away.September 21, 2020
- PNAS
Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malariaSeptember 18, 2020
- BioCentury
What it will take to get to mass asymptomatic screening for COVID-19September 15, 2020
Co-founder Rahul Dhanda on The 221B Foundation:
September 15, 2020
- The Science Advisory Board
Sherlock launches nonprofit to promote equity, STEM during COVID-19September 15, 2020
Sherlock Biosciences Launches The 221b Foundation to Address the COVID-19 Pandemic and Equity in STEMSeptember 09, 2020
Sherlock Biosciences Appoints Dr. Martin Madaus as Chief Operations OfficerSeptember 15, 2020, 1pm-2:15pm ET - Bio IP Committee Counsel
Webinar: To Pool, Pledge, or License – Allocating IP Rights during COVID-19 R&DSeptember 29th - October 1st, 2020
The Global Synthetic Biology Conference 2020September 01, 2020
- Genetic Engineering & Biotechnology News
Genetic Engineering, No Virus RequiredSeptember 01, 2020
Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 KitAugust 29, 2020
- Washington Post
Months into the pandemic, still no easy answers on coronavirus testingAugust 16, 2020
- NBC News Los Angeles
At-Home COVID-19 Tests Could Happen Sooner Than You Think, Thanks to Tech BreakthroughsAugust 12, 2020
Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2August 12, 2020, MassBio Webinar
Implementing COVID-19 Testing in Massachusetts Phased Reopening PlansAugust 5, 2020, BioCentury Webinar
Good Test Hunting: The Road to Testing that Enables ReopeningJuly 14, 2020
- CommonHealth
CRISPR Comes To COVID: A Pandemic Pivot And The Push For A Simple Coronavirus TestJuly 01, 2020
- Forbes
A New 20-Minute Covid-19 Test Will Use CRISPR Gene Editing Technology To Deliver Results At The Doctor’s Office, Supermarket, Or WorkplaceJuly 01, 2020
Sherlock Biosciences and binx health Announce Global Partnership to Develop First CRISPR-based Point-of-care Test for COVID-19June 30, 2020, Partner Webinar with IDT
Increasing Testing Capacity for COVID-19 with Sherlock CRISPR-Based DiagnosticsJune 16, 2020, World Economic Forum Webinar
Pivoting Your Business to Diagnostics: Lessons from Gene Technology StartupsMay 07, 2020
Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid DiagnosticMay 07, 2020
- BioCentury
CRISPR comes of age years ahead of schedule with first diagnostic authorizationMarch 25, 2020
- FierceBiotech
Sherlock Bio, Cepheid pair up to develop CRISPR diagnostics for coronavirus and moreMarch 19, 2020
- Boston Globe
Massachusetts life-sciences industry at forefront of worldwide fight against coronavirusFebruary 28, 2020
Cepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR TechnologyDecember 05, 2019
Evercore ISI HealthCONx Conference 2019December 04, 2019
Cell Free Systems Conference 2019December 02, 2019
Sherlock Biosciences Announces Two Upcoming December ConferencesOctober 31, 2019
- GENOME WEB
Sherlock Biosciences Aims to Create Dx Tool for ‘Where Testing Should be Done, But Isn’t‘October 31, 2019
- Genetic Engineering & Biotechnology News
Forces Unite to Move Molecular Dx Out of the GatesOctober 29, 2019
Sherlock Biosciences and Mologic Establish Strategic Partnership to Develop Instrument-free Molecular Diagnostic TestsSeptember 26, 2019
- BOSTON BUSINESS JOURNAL
Sherlock Bio gets DoD grant to bring CRISPR to the battlefieldSeptember 26, 2019
Sherlock Biosciences Awarded Contract from U.S. Defense Threat Reduction Agency to Support the Development of Ultra-Fast, Ultra-Sensitive DiagnosticsSeptember 24, 2019
- BostInno
Sherlock Named one of BostInno’s 2019 50 on Fire Recipients in Health CareApril 23, 2019
Sherlock Biosciences Announces Close of Series A Round with Additional Investment Led by Northpond Ventures and Baidu VenturesMarch 21, 2019
Sherlock Biosciences Launches to Provide Better, Faster and More Affordable Diagnostic Testing Worldwide Through Engineering BiologyApril 13, 2017
- STAT News
CRISPR cousin SHERLOCK may be able to track down diseases, scientists sayApril 13, 2017
- Washington Post
A new CRISPR breakthrough could lead to simpler, cheaper disease diagnosisApril 27, 2018
- Science
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6August 05, 2016
- Science
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector